Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses

The epidemiology of bacterial vaginosis in relation to sexual behaviour

(2010) Hans Verstraelen et al.   BMC INFECTIOUS DISEASES

Long-term vaginal administration ofLactobacillus rhamnosusas a complementary approach to management of bacterial vaginosis

(2010) Valentina Marcone et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Quantitative PCR Assessments of Bacterial Species in Women with and without Bacterial Vaginosis

(2010) M. Zozaya-Hinchliffe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis

(2010) Sophia Ehrström et al.   MICROBES AND INFECTION

Established and potential risk factors forclostridum difficileinfection

(2009) C Vaishnavi   Indian Journal of Medical Microbiology

Vaginal Colonization by ProbioticLactobacillus crispatusCTV‐05 Is Decreased by Sexual Activity and Endogenous Lactobacilli

(2009) May A. D. Antonio et al.   JOURNAL OF INFECTIOUS DISEASES

Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study

(2008) Per-Göran Larsson et al.   BMC Womens Health